Half-year report · HY
7747.TEDINET S100XKTG
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥71.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥120.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥24.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥24.1bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥29.6bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥24.8bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥17.2bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.7bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥17.3bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥195.9bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥193.2bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.2bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥41.8bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.7bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥151.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥53.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥54.2bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.5bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥17.8bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥40.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥957m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.4bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥18.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.1bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥64.56 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.92 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.6% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.9% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.0bn |
| Devicereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥16.9bn |
| Devicereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥8.6bn |
| Devicereportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Devicereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.4bn |
| Medicalreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥23.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥79.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥71.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥28.3bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 4182000000 | JPY |
| Other ncl | InterimInstant | 5835000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 13976000000 | JPY |
| Noncurrent liabilities | InterimInstant | 14838000000 | JPY |
| Liabilities | Prior1YearInstant | 41833000000 | JPY |
| Liabilities | InterimInstant | 37198000000 | JPY |
| Capital stock | Prior1YearInstant | 18860000000 | JPY |
| Capital stock | InterimInstant | 18860000000 | JPY |
| Capital surplus | Prior1YearInstant | 21779000000 | JPY |
| Capital surplus | InterimInstant | 18872000000 | JPY |
| Retained earnings | Prior1YearInstant | 97947000000 | JPY |
| Retained earnings | InterimInstant | 96573000000 | JPY |
| Treasury stock | Prior1YearInstant | -4453000000 | JPY |
| Treasury stock | InterimInstant | -18000000 | JPY |
| Shareholders equity | Prior1YearInstant | 134134000000 | JPY |
| Shareholders equity | InterimInstant | 134287000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 2008000000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 2228000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 14315000000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 21192000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 99000000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 67000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 16424000000 | JPY |
| Valuation and translation adjustments | InterimInstant | 23488000000 | JPY |
| Non controlling interests | Prior1YearInstant | 795000000 | JPY |
| Non controlling interests | InterimInstant | 896000000 | JPY |
| Net assets | Prior1YearInstant | 151354000000 | JPY |
| Net assets | InterimInstant | 158671000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 193187000000 | JPY |
| Liabilities and net assets | InterimInstant | 195870000000 | JPY |
| Net sales | Prior1InterimDuration | 61491000000 | JPY |
| Net sales | InterimDuration | 71266000000 | JPY |
| Cost of sales | Prior1InterimDuration | 19941000000 | JPY |
| Cost of sales | InterimDuration | 20955000000 | JPY |
| Gross profit | Prior1InterimDuration | 41549000000 | JPY |
| Gross profit | InterimDuration | 50311000000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 24154000000 | JPY |
| Selling general and administrative expenses | InterimDuration | 25939000000 | JPY |
| Operating income | Prior1InterimDuration | 17395000000 | JPY |
| Operating income | InterimDuration | 24372000000 | JPY |
| Interest income noi | Prior1InterimDuration | 48000000 | JPY |
| Interest income noi | InterimDuration | 100000000 | JPY |
| Dividends income noi | Prior1InterimDuration | 81000000 | JPY |
| Dividends income noi | InterimDuration | 48000000 | JPY |
| Subsidy income noi | Prior1InterimDuration | 155000000 | JPY |
| Subsidy income noi | InterimDuration | 122000000 | JPY |
| Other noi | Prior1InterimDuration | 157000000 | JPY |
| Other noi | InterimDuration | 85000000 | JPY |
| Non operating income | Prior1InterimDuration | 442000000 | JPY |
| Non operating income | InterimDuration | 356000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |